Kieran Gallahue, Director at Intersect ENT, Inc. (XENT), bought 8,000 shares at $12.64 ($101K) on 2016-05-16, disclosed to the SEC on 2016-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| EW | BUY | 2017-02-06 | $270K | — | Filing → |
| EW | BUY | 2016-12-01 | $254K | — | Filing → |
| CFN | SELL | 2014-05-20 | $4.3M | — | Filing → |